Drug Search Results
Using advanced filters...
Advanced Search [+]

Norethandrolone

Alternative Names: norethandrolone
Latest Update: 2023-11-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: GR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: France

Approved Indications: None

Known Adverse Events: None

Company: University Hospital, Grenoble
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Acute Myeloid Leukemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

LAM SA 2002

P3

Completed

Acute Myeloid Leukemia

2005-04-01

Recent News Events